Satellos Bioscience Inc. Common Stock (MSLE) is a publicly traded the market company. As of May 21, 2026, MSLE trades at $7.35 with a market cap of $148.94M and a P/E ratio of 0.00. MSLE moved +3.43% today. Year to date, MSLE is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $5.50 to $13.39. Analyst consensus is strong buy with an average price target of $22.00. Rallies surfaces MSLE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Satellos Bioscience Inc. Common Stock (MSLE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MSLE moved +3.43% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $7.35 |
| Market Cap | $148.94M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.39 |
| 52-Week Low | $5.50 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover MSLE: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.00.